| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 23 |
| 1 | DALFAMPRIDINE | 21 |
| 2 | ADALIMUMAB | 12 |
| 3 | ERGOCALCIFEROL | 12 |
| 4 | METHOTREXATE SODIUM | 12 |
| 5 | RITUXIMAB | 12 |
| 6 | ACETAMINOPHEN | 11 |
| 7 | NATALIZUMAB | 11 |
| 8 | IBUPROFEN | 10 |
| 9 | ACETAMINOPHEN 500MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRIOL | 2 | 0.0011 |
| 1 | ALDESLEUKIN | 1 | 0.0008 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 6 | 0.0007 |
| 3 | DICLOFENAC SODIUM AND MISOPROSTOL | 4 | 0.0006 |
| 4 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 5 | ATAZANAVIR | 7 | 0.0005 |
| 6 | AVATROMBOPAG MALEATE | 1 | 0.0004 |
| 7 | CABERGOLINE | 2 | 0.0004 |
| 8 | ERGOCALCIFEROL | 12 | 0.0004 |
| 9 | FINGOLIMOD HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 3 | Potassium Channel Blocker [EPC] | 21 | 0.0003 |
| 4 | Sympathomimetic-like Agent [EPC] | 9 | 0.0003 |
| 5 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 10 | 0.0002 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |